Inactive Instrument

Skyline Medical Inc Stock price Nasdaq

Equities

US83084T6064

Medical Equipment, Supplies & Distribution

Sales 2021 1.42M Sales 2022 1.51M Capitalization 24.15M
Net income 2021 -19M Net income 2022 -25M EV / Sales 2021 24.7 x
Net cash position 2021 27.32M Net cash position 2022 21.89M EV / Sales 2022 1.5 x
P/E ratio 2021
-2.64 x
P/E ratio 2022
-0.87 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 96.86%
More Fundamentals * Assessed data
Dynamic Chart
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates in three segments based on location and specialty: the Pittsburgh segment provides services that include the application of AI using its biobank of 150,000+ cancer tumor samples. Pittsburgh also utilizes three-dimensional (3D) culture models in drug development. The Birmingham segment provides services and research using a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens, using additives and excipients included in protein formulations resulting in soluble and physically stable formulations of biologics focused on solubility improvements, stability studies, and protein production. The Eagan (Minnesota) segment consists of the production of the STREAMWAY System for automated fluid waste management, direct-to-drain medical fluid disposal, and associated products.
More about the company
  1. Stock
  2. Equities
  3. Stock Predictive Oncology Inc.
  4. Stock Skyline Medical Inc - Nasdaq